Skip to content

Integer Holdings ITGR Research and development expense

Research and development expense at other companies

Boston Scientific logo
Boston ScientificBSX
$516M+16.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
Medtronic logo
MedtronicMDT
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
Penumbra logo
PenumbraPEN

Segments

By segment

See full
Reportable Segment$49.5M-7.3%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's research and development expense?
Integer Holdings (ITGR) reported research and development expense of $16.24M in Q1 2026.
How has Integer Holdings's research and development expense changed year-over-year?
Integer Holdings's research and development expense increased by 14.4% year-over-year, from $14.2M to $16.24M.
What is the long-term trend for Integer Holdings's research and development expense?
Over 4 years (2021 to 2025), Integer Holdings's research and development expense has grown at a -1.2% compound annual growth rate (CAGR), from $51.99M to $49.5M.